3.42
-0.3(-8.06%)
Currency In USD
| Previous Close | 3.72 |
| Open | 3.64 |
| Day High | 3.7 |
| Day Low | 3.38 |
| 52-Week High | 12.36 |
| 52-Week Low | 3.38 |
| Volume | 18.84M |
| Average Volume | 22.29M |
| Market Cap | 1.37B |
| PE | -1.86 |
| EPS | -1.84 |
| Moving Average 50 Days | 4.39 |
| Moving Average 200 Days | 4.92 |
| Change | -0.3 |
If you invested $1000 in Recursion Pharmaceuticals, Inc. (RXRX) since IPO date, it would be worth $109.27 as of February 21, 2026 at a share price of $3.42. Whereas If you bought $1000 worth of Recursion Pharmaceuticals, Inc. (RXRX) shares 3 years ago, it would be worth $443.58 as of February 21, 2026 at a share price of $3.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
GlobeNewswire Inc.
Feb 18, 2026 1:30 PM GMT
Company to host public (L)earnings call on February 25 at 8:00 am ET / 6:00 am MT / 1:00 pm GMTSalt Lake City, UT, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically im
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
GlobeNewswire Inc.
Feb 12, 2026 12:59 PM GMT
Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Bo
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2026 12:59 PM GMT
Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January